Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB14015ApprovedWithdrawnSmall molecule
Sodium bisulfite is an ingredient in parenteral nutrition products for patients with severe liver disorders. Sodium bisulfite has been used externally for parasitic skin diseases and as a gastrointestinal antiseptic.
- Formula / weight
- HNaO3S · 104.061 g/mol (avg)
- First approval
- Canada, 1998
- Also known as
- sodium bisulphite · sodium hydrogen sulfite · sodium hydrogensulfite
- Code names
- E222
Resolves to
Clinical / RWD
Structure
InChIKey
DWAQJAXMDSEUJJ-UHFFFAOYSA-MSMILES[Na+].OS([O-])=OTargets
What you can answer from here — as of July 07, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Sodium bisulfite, and which of those have an active Phase 3 trial?